> MEDIA   Overview   Press Releases   Media Stories   Download Center   Video Gallery   Photo Gallery   Media Contacts

Press Releases 2017 2018 2019 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005       November 2012 16 Nov  Biocon announces that it has entered into  an option agreement with Bristol-Myers  Squibb for Biocon's IN-105, an oral insulin  drug candidate   October 2012 31 Oct  Biocon Announces Positive Results from its  Global Phase 3 study with Recombinant  Human Insulin 31 Oct  GE Capital to invest in Syngene, Biocon's  Research Services Subsidiary 30 Oct  Biocon delivers healthy growth in H1FY13  Research Services & Branded Formulations  propel strong growth   September 2012 24 Sep  Biocon - the only Asian Company to  Feature in the Global Top 20 BioPharma  Employers 14 Sep  Manipal Education Malaysia and Biocon Ink  Industry Academia Partnership for the  Graduate Program & Talent Management  for Biotech Sector   July 2012 25 Jul  Sustained impetus across verticals drives  Biocon's Q1 growth 25 Jul  Biocon announces positive results from its  Phase 1 Comparative PK-PD Study with  Biosimilar Insulin Glargine   June 2012 04 Jun  Abbott Inaugurates First Nutrition R&D  Center in India in Collaboration with  Syngene   May 2012 16 May  Designing the future of Cancer research  Symposium on Integrative Research in  Oncology 04 May  Abbott Announces Collaboration with  Syngene to Open First Nutrition Research  and Development Center in India   April 2012 27 Apr  Biocon announces strong growth  momentum across business verticals drives  Biocon's 16% YoY increase in revenues in  FY12 05 Apr  Biocon Research Centre Inaugurated by  Nobel Laureate Prof Kurt Wuthrich   March 2012 13 Mar  Biocon and Pfizer Conclude  Commercialization Agreement   January 2012 24 Jan  Biocon's nine-month revenues driven by  growth in Branded Formulations, Emerging  Markets and Research Services 09 Jan  Biocon Announces Positive Efficacy Data  with its Novel Monoclonal Antibody  Itolizumab in a Pivotal Psoriasis Study

Biocon Businesses Recommended sites Biocon on     Home About Us Investor Relations Media Relations Careers Site Map Contact Us Our Growth Accelerators Fact Sheet Branded Formulations Biopharmaceuticals Research Services Active Discovery Program ABLE Karnataka Vision Group on BT Syngene International Biocon Academy                   Report adverse event/side effects and product complaints               * Disclaimer            © 2018, Biocon. All Rights Reserved